There are about 500 women who used Fosamax, suffered femur fractures, and then filed a product liability lawsuit against Merck. Their lawsuit had been pending in the federal court Fosamax MDL for ten years or more. In an unfortunate but not altogether unexpected development, in March 2022 their Fosamax lawsuits were dismissed a second time as a … [Read more...]
Merck Wants The US Supreme Court To End Fosamax – Femur Fracture Cases
On August 22, 2017 attorneys for Merck filed their Petition For A Writ Of Certiorari, which sets the stage for Merck’s Fosamax appeal to the Supreme Court with the following: The question presented is: Is a state-law failure-to-warn claim preempted when the FDA rejected the drug manufacturer’s proposal to warn about the risk after being provided … [Read more...]
Appeals Court Reverses Dismissal Of Fosamax – Femur Fracture Lawsuits
A recent ruling on the long-pending appeals in the so-called federal court Fosamax MDL — In re: Fosamax (Alendronate Sodium) Products Liability Litigation — is a positive development for the patients who suffered femur fractures after long-term Fosamax use and filed drug injury lawsuits against Merck. On March 22, 2017 the Third Circuit Court of … [Read more...]
Fosamax – Femur Fracture Lawsuits Wait On Rulings By Court Of Appeals
The federal court Fosamax – femur fracture MDL has been in a “holding pattern” while the parties wait for the appellate court to issue rulings on at least two appeals regarding the Fosamax label, or package insert, information about the femur fracture side effect. And for the New Jersey state court Fosamax litigation, it appears that the presiding … [Read more...]